Non-globular proteins in the era of Machine Learning

COST Action CA21160

YRI CONFERENCE GRANTS

Description

YRI Conference Grants aimed at supporting Young Researchers and Innovators* to present (oral or poster) their own work within the scope of the Action in a high-level conference fully organized by a third party, i.e. not organized nor co-organized by the COST Action.

YRI Conference grant:

  • Serves COST Excellence and Inclusiveness Policy;
  • Supports YRI to establish a strong network and increase their visibility in the research community through sharing their work and to gain knowledge;
  • Can contribute to increasing visibility of the Action.

A number of YRI Conference Grants were financed each year as defined by the rules of the COST framework. 

*COST defines a Young Researcher or Innovator as someone under the age of 40

In the selection process of YRI CG applications, ML4NGP Action will ensure geographical diversity, gender balance and empowerment of young researchers.

APPLICATIONS FOR YRI CGs ARE CLOSED.

FEEDBACK FROM SELECTED CANDIDATES

I am very grateful to have been able to attend the ECIS conference this year, where I showcased my work studying squid peptide coacervate delivery systems. At the conference I meet scientists from ILL (France) and PSI (Switzerland) for the 1st time, and was able to discuss potential future experiments and methods. I also was able to re-connect with many people from my network from across the world (RMIT Australia, Aarhus University Denmark, BCM materials, Spain).

Claire Buchanan, Spain Attendee at 39th European Colloids and Interface Society (ECIS) conference, UK (2025)

My participation was made possible through the generous support of the YRI Conference Grant, to which I am deeply grateful. Their support enabled me not only to attend and present but also to engage with international researchers, explore new research perspectives, and form new collaborations. This experience has opened doors to new ideas and further confirmed the importance of interdisciplinary exchange. Most importantly, the feedback and new project opportunities I received have greatly motivated me to continue my research.

Emre Aktas, Turkiye Attendee at 9th International Conference on Biomedical Engineering and Bioinformatics, Czech Republic (2025)

My presentation at MSS26 successfully achieved its primary goal: to highlight the importance of Intrinsically Disordered Proteins (IDPs) and direct the attention of the Atlas of Variant Effects (AVE) community toward the necessity of including IDPs in mutational studies. By demonstrating that current Variant Effect Predictors (VEPs), clinical assessments, and experimental pipelines exhibit a significant bias in disordered regions, the audience acknowledged this critical gap, which significantly increased the visibility of our research.

Norbert Deutsch, Hungary Attendee at Mutational Scanning Symposium 2026, Australia

Participation in BelBi enabled me to establish new connections with researchers from the Balkan region, expanding both my professional network and the reach of the ML4NGP COST Action within a scientific community I was not previously exposed to. Overall, participation in BelBi 2026 successfully enhanced the visibility of my research, strengthened existing professional relationships, established new international contacts, and created opportunities for future collaborations while supporting the dissemination and outreach objectives of the ML4NGP COST Action.

Gonzalo R. Parra, Spain Attendee at BelBi 2026 - Belgrade Bioinformatics Conference, Serbia (2026)